We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$24.2B
AUM Growth
+$1.8B
Cap. Flow
+$1.96B
Cap. Flow %
8.1%
Top 10 Hldgs %
25.17%
Holding
1,081
New
153
Increased
475
Reduced
286
Closed
135

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$134M
2
MA icon
Mastercard
MA
+$112M
3
AAPL icon
Apple
AAPL
+$103M
4
NVDA icon
NVIDIA
NVDA
+$94.9M
5
SCHW
Charles Schwab
SCHW
+$93.6M

Sector Composition

Rank Sector Weight
1 Technology 31.44%
2 Financials 13.67%
3 Consumer Discretionary 12.77%
4 Industrials 11.01%
5 Healthcare 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCKT icon
1001
Hackett Group
HCKT
$245M
-13,744
Closed -$334K
HE icon
1002
Hawaiian Electric Industries
HE
$2.33B
-24,776
Closed -$279K
HPE icon
1003
Hewlett Packard
HPE
$63.2B
-232,632
Closed -$4.12M
IFF icon
1004
International Flavors & Fragrances
IFF
$19.4B
-14,103
Closed -$1.21M
IGMS
1005
DELISTED
IGM Biosciences
IGMS
-78,580
Closed -$758K
IPAR icon
1006
Interparfums
IPAR
$3.92B
-4,274
Closed -$601K
JAZZ icon
1007
Jazz Pharmaceuticals
JAZZ
$15.9B
-30,545
Closed -$3.68M
KZR
1008
DELISTED
Kezar Life Sciences
KZR
-5,322
Closed -$48K
LAZ icon
1009
Lazard
LAZ
$4.37B
-23,469
Closed -$983K
LGND icon
1010
Ligand Pharmaceuticals
LGND
$6.02B
-14,762
Closed -$1.08M
LPSN icon
1011
LivePerson
LPSN
$18.9M
-15,505
Closed -$232K
MC icon
1012
Moelis & Co
MC
$4.98B
-7,558
Closed -$429K
MP icon
1013
MP Materials
MP
$7.35B
-334,976
Closed -$4.79M
MRVI icon
1014
Maravai LifeSciences
MRVI
$997M
-57,076
Closed -$495K
MSEX icon
1015
Middlesex Water
MSEX
$1.05B
-21,203
Closed -$1.11M
MVST icon
1016
Microvast
MVST
$267M
-3,308,277
Closed -$2.77M
NRGV icon
1017
Energy Vault
NRGV
$522M
-51,037
Closed -$91.4K
NVCR icon
1018
NovoCure
NVCR
$2.04B
-475,226
Closed -$7.43M
OFIX icon
1019
Orthofix Medical
OFIX
$455M
-391,327
Closed -$5.68M
OGS icon
1020
ONE Gas
OGS
$5.05B
-60,086
Closed -$3.88M
OMCL icon
1021
Omnicell
OMCL
$1.86B
-73,506
Closed -$2.15M
OVID icon
1022
Ovid Therapeutics
OVID
$435M
-62,341
Closed -$190K
PARA
1023
DELISTED
Paramount Global Class B
PARA
-1,738,661
Closed -$20.5M
PHAT icon
1024
Phathom Pharmaceuticals
PHAT
$912M
-20,987
Closed -$223K
PINC
1025
DELISTED
Premier
PINC
-282,812
Closed -$6.25M

Similar funds

Jacobs Levy Equity Management's Q2 2024 Portfolio in Review

As of Q2 2024, Jacobs Levy Equity Management held 1,081 positions worth $24.2B, up 8.1% from $22.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management deployed $1.96B of net new capital in Q2 2024, opening 153 new positions and adding to 475 existing holdings. Its largest new stake was Constellation Energy: 961,483 shares worth $193M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Incyte, an estimated $134M trimmed.

  • Jacobs Levy Equity Management's largest Q2 2024 buy was Constellation Energy: 961,483 shares worth $193M.
  • Jacobs Levy Equity Management added most to JB Hunt Transport Services in Q2 2024, an estimated $148M increase.
  • Jacobs Levy Equity Management's biggest Q2 2024 reduction was Incyte, cutting an estimated $134M.
  • Jacobs Levy Equity Management fully exited Zscaler in Q2 2024, selling an estimated $38.6M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $24.2B portfolio in Q2 2024.
  • Jacobs Levy Equity Management opened 153 new positions and closed 135 in Q2 2024.
  • Jacobs Levy Equity Management's portfolio value rose 8.1% quarter-over-quarter to $24.2B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2024, filed 14 Aug 2024.